SCHEMBL5196825

SCHEMBL5196825

C=CCOC(=O)N1C[CH]CC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
CYP3A4 P08684 1/20 0.36
ERN1 O75460 8/20 0.35
GPR119 Q8TDV5 1/20 0.34
SLC6A15 Q9H2J7 1/20 0.33
CHRM1 P11229 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NR1D1 P20393 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
MAPT P10636 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2985134 0.89 LMNA (0.46) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL9191402 0.85 LMNA (0.42) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL1712987 0.78 TSHR (0.48) LMNATSHRALDH1A1MAPT
SCHEMBL8924794 0.78 LMNA (0.42) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL4195614 0.76 LMNA (0.46) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL3992214 0.74 LMNA (0.45) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL3997516 0.74 LMNA (0.45) LMNAMAPK1RAB9ACYP3A4ERN1
SCHEMBL1713224 0.74 NOTUM (0.34) TSHR
SCHEMBL1713612 0.74 SMN1; SMN2 (0.42) LMNATSHRALDH1A1MAPT
SCHEMBL30564477 0.73 LMNA (0.40) LMNAMAPK1RAB9ACYP3A4ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1067131-B1 New process for the manufacture of cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-08-15 EP claimed
US-6384214-B1 ALKALINE CONVERSION OF PYRROLIDINYL PHOSHONIUM SALT TO YLIDE FOLLOWED BY COUPLING WITH A 5-THIA-1-AZABICYCLOOCTANE 2-ALDEHYDE; ISOMERIZATION INHIBITION BASILEA PHARMACEUTICA AG (CH) 2002-05-07 US claimed
EP-1067131-A1 New process for the manufacture of cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-10 EP claimed
EP-1067131-B1 New process for the manufacture of cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-08-15 EP disclosed
US-6384214-B1 ALKALINE CONVERSION OF PYRROLIDINYL PHOSHONIUM SALT TO YLIDE FOLLOWED BY COUPLING WITH A 5-THIA-1-AZABICYCLOOCTANE 2-ALDEHYDE; ISOMERIZATION INHIBITION BASILEA PHARMACEUTICA AG (CH) 2002-05-07 US disclosed
EP-1067131-A1 New process for the manufacture of cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-10 EP disclosed
EP-0330108-B1 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO (JP) 1995-12-27 EP disclosed
US-5081237-A Chemical intermediates for bactericides FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-01-14 US disclosed
US-4923857-A CARBAPENICILLINS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-08 US disclosed
EP-0330108-A1 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-08-30 EP disclosed